These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vivo biotinylated recombinant antibodies: construction, characterization, and application of a bifunctional Fab-BCCP fusion protein produced in Escherichia coli. Weiss E; Chatellier J; Orfanoudakis G Protein Expr Purif; 1994 Oct; 5(5):509-17. PubMed ID: 7827508 [TBL] [Abstract][Full Text] [Related]
5. [Expression and identification of phage display library for Fab fragments of colorectal cancer-related antibodies]. Sun X; Wu BP; Xiao B; Zhang ZS; Lai ZS Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):678-83. PubMed ID: 12376247 [TBL] [Abstract][Full Text] [Related]
6. Rapid kinetic-based screening of human Fab fragments. Steukers M; Schaus JM; van Gool R; Hoyoux A; Richalet P; Sexton DJ; Nixon AE; Vanhove M J Immunol Methods; 2006 Mar; 310(1-2):126-35. PubMed ID: 16481004 [TBL] [Abstract][Full Text] [Related]
7. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains. Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. Wang X; Campoli M; Ko E; Luo W; Ferrone S J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013 [TBL] [Abstract][Full Text] [Related]
9. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655 [TBL] [Abstract][Full Text] [Related]
10. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546 [TBL] [Abstract][Full Text] [Related]
11. Size of the ligand complex between the N-terminal domain of the gene III coat protein and the non-infectious phage strongly influences the usefulness of in vitro selective infective phage technology. Cèbe R; Geiser M Biochem J; 2000 Dec; 352 Pt 3(Pt 3):841-9. PubMed ID: 11104694 [TBL] [Abstract][Full Text] [Related]
12. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583 [TBL] [Abstract][Full Text] [Related]
13. Antibody Fab display and selection through fusion to the pIX coat protein of filamentous phage. Tornetta M; Baker S; Whitaker B; Lu J; Chen Q; Pisors E; Shi L; Luo J; Sweet R; Tsui P J Immunol Methods; 2010 Aug; 360(1-2):39-46. PubMed ID: 20600082 [TBL] [Abstract][Full Text] [Related]
14. Bacterial expression and purification of recombinant bovine Fab fragments. O'Brien PM; Maxwell G; Campo MS Protein Expr Purif; 2002 Feb; 24(1):43-50. PubMed ID: 11812221 [TBL] [Abstract][Full Text] [Related]
15. A new helper phage for improved monovalent display of Fab molecules. Beaber JW; Tam EM; Lao LS; Rondon IJ J Immunol Methods; 2012 Feb; 376(1-2):46-54. PubMed ID: 22119405 [TBL] [Abstract][Full Text] [Related]
16. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor. Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620 [TBL] [Abstract][Full Text] [Related]
17. New display vector reduces biological bias for expression of antibodies in E. coli. Pavoni E; Monteriù G; Cianfriglia M; Minenkova O Gene; 2007 Apr; 391(1-2):120-9. PubMed ID: 17267141 [TBL] [Abstract][Full Text] [Related]
18. Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression. Harvey BR; Shanafelt AB; Baburina I; Hui R; Vitone S; Iverson BL; Georgiou G J Immunol Methods; 2006 Jan; 308(1-2):43-52. PubMed ID: 16337958 [TBL] [Abstract][Full Text] [Related]
19. Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen. Maeda F; Nagatsuka Y; Ihara S; Aotsuka S; Ono Y; Inoko H; Takekoshi M J Med Virol; 1999 Aug; 58(4):338-45. PubMed ID: 10421399 [TBL] [Abstract][Full Text] [Related]
20. Use of phage display for the generation of human antibodies that neutralize factor IXa function. Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]